Abravan, A.
101  results:
Search for persons X
?
1

EP08.01-03 Lymphocyte Count Pre-immunotherapy Predicts Prog..:

Abravan, A. ; Horne, A. ; van Herk, M...
Journal of Thoracic Oncology.  18 (2023)  11 - p. S567 , 2023
 
?
3

PO-1676 Optimising heart substructure visibility in 4D plan..:

van Herk, M. ; Marchant, T. ; Henderson, E....
Radiotherapy and Oncology.  182 (2023)  - p. S1381-S1382 , 2023
 
?
5

Evaluation of Observer Variation as Natural Experiment to D..:

van Herk, M. ; Abravan, A. ; Faivre-Finn, C..
International Journal of Radiation Oncology*Biology*Physics.  117 (2023)  2 - p. e489 , 2023
 
?
6

MO-0638 Frequency of cardiac hospitalization early after lu..:

Abravan, A. ; Price, G. ; Mcwilliam, A...
Radiotherapy and Oncology.  182 (2023)  - p. S528-S529 , 2023
 
?
7

OC-0259 Diversity, equity, and inclusion within radiation o..:

Abravan, A. ; Correia, D. ; Gasnier, A....
Radiotherapy and Oncology.  182 (2023)  - p. S196-S197 , 2023
 
?
8

MO-0471 Post-radiotherapy G3+ esophageal toxicity predictor..:

Abravan, A. ; Mistry, H. ; Mcwilliam, A....
Radiotherapy and Oncology.  182 (2023)  - p. S376-S378 , 2023
 
?
9

PD-0671 Impact of FDG PET in small-cell lung cancer patient..:

Salem, A. ; Abravan, A. ; Sandhu, L....
Radiotherapy and Oncology.  170 (2022)  - p. S605-S607 , 2022
 
?
10

EP05.01-010 External Validation of Two Prediction Models fo..:

van Rossum, P. ; Stam, B. ; Juan-Cruz, C....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S270-S271 , 2022
 
?
 
?
12

SP-0193 How can we reduce the chance of patients developing..:

Abravan, A.
Radiotherapy and Oncology.  170 (2022)  - p. S160 , 2022
 
?
 
?
 
?
15

PD-0164 Proton therapy reduces the incidence of severe lymp..:

Abravan, A. ; Sitch, P. ; van Herk, M....
Radiotherapy and Oncology.  170 (2022)  - p. S140-S141 , 2022
 
1-15